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Abstract. Dilatation of the cerebral ventricles is a common condition in preterm neonates with intraventricular
hemorrhage. This posthemorrhagic ventricle dilatation (PHVD) can lead to lifelong neurological impairment
through ischemic injury due to increased intracranial pressure, and without treatment can lead to death.
Two-dimensional ultrasound (US) through the fontanelles of the patients is serially acquired to monitor the pro-
gression of PHVD. These images are used in conjunction with clinical experience and physical exams to deter-
mine when interventional therapies such as needle aspiration of the built up cerebrospinal fluid (ventricle tap, VT)
might be indicated for a patient; however, quantitative measurements of the ventricles size are often not per-
formed. We describe the potential utility of the quantitative three-dimensional (3-D) US measurements of ven-
tricle volumes (VVs) in 38 preterm neonates to monitor and manage PHVD. Specifically, we determined 3-D US
VV thresholds for patients who received VT in comparison to patients with PHVD who resolve without interven-
tion. In addition, since many patients who have an initial VT will receive subsequent interventions, we determined
which PHVD patients will receive additional VT after the initial one has been performed. © The Authors. Published by
SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of
the original publication, including its DOI. [DOI: 10.1117/1.JMI.5.2.026001]
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1 Introduction
Despite advances in neonatal care and improved evidence-based
perinatal management guidelines, preterm neonates are still at a
high risk of morbidity. Intraventricular hemorrhage (IVH),
bleeding inside the cerebral ventricles, has been decreasing in
prevalence yet remains as a common morbidity among preterm
born neonates.1 The risk of long-term disabilities such as cer-
ebral palsy and cognitive impairment increases significantly
with the occurrence of posthemorrhagic hydrocephalus (PHH),
the abnormal enlargement of the ventricles, which typically
occurs in 25% to 28% of IVH patients with severe bleeds
(grades III and IV by the Papile scale2).3 In general, PHH is
thought to be caused by the blood clots and inflammatory reac-
tions from blood breakdown products causing obstruction of the
flow of CSF, which normally flows from the ventricles, where
CSF is generated to the subarachnoid space where it is reab-
sorbed into the blood stream.
While the definitive treatment for PHH is the placement of a
ventriculoperitoneal shunt (tubing between the ventricles and
the abdomen), placement of the shunt is often delayed by several
weeks to allow for the blood clot to resolve, the CSF proteins to
decrease (<1000 mg∕dL), and the weight of the infant to
increase (at minimum >800 g to 1 kg). However, during this
delay in treatment, the increase in ventricle size, also known
as posthemorrhagic ventricle dilatation (PHVD), can cause dan-
gerously increased intracranial pressure (ICP), which can limit
blood flow to the brain. Any ischemia or decreased blood flow
during this critical period can be detrimental to the developing
brain and can lead to impairment later in life. Due to this risk,
neonates who have rapidly progressing PHVD and some with
persistent, slowly progressing PHVD will require temporary
interventions to relieve the elevated ICP. These interventions
include lumbar/ventricle puncture, external ventricle drainage,
ventricular access devices (reservoirs), and ventriculosubgaleal
shunts. There is no consensus of evidence as to which of these
methods are the best for temporary CSF diversion.4,5
Currently, clinical experience as well as daily head circum-
ference and transfontanelle brain ultrasound (US) are used to
determine when neonates receive temporary interventions to
removed built up CSF.6 However, it has been shown that
head circumference does not accurately correlate with increase
in clinical US measurements (Evan’s ratio)7 or with ventricular
volume.8 In addition, clinical signs of increased ICP (apnea and
bradycardia) are nonspecific in the preterm infant and could be
due to other comorbidities. Early detection of interventional
necessity could potentially lead to better management of the
condition, while early detection of resolution could provide
comfort to the clinician and parents that intervention is unlikely
to be necessary. In addition, since many cases of PHVD resolve*Address all correspondence to: Jessica Kishimoto, E-mail: jkishimo@uwo.ca
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after a temporizing CSF diversion procedure and do not
then require a shunt, we aimed to characterize an US-based
metric to determine the resolution of PHVD versus continual,
progressive ventricle dilatation leading to PHH, which may
receive additional interventions.
Previous work with transfontanelle brain three-dimensional
(3-D) US has been attempted in neonates.9–13 While this imag-
ing technique was shown to be feasible and gives similar
measurements14 and diagnosis12,15,16 as two-dimensional (2-D)
US, its clinical utility beyond 2-D has not been established.
Recent studies have had success acquiring 3-D US images of
neonatal ventricles using commercial systems;9,10,12,14–16 how-
ever, these transducers are not part of standard-of-care and
must be purchased separately. The expense of these systems
may limit their use, especially in the developing world. A sys-
tem that could be used in conjunction with a conventional clini-
cal 2-D transducer to generate full 3-D images would allow
centers without a 3-D US capable machine to confidently
acquire 3-D ventricle volumes (VVs). As hydrocephalus is
far from only an issue in the developed world with 6000
cases per year diagnosed in East Africa,17 we developed a rel-
atively low-cost 3-D US system that can be modified to generate
3-D US images from virtually any conventional 2-D US
system.18 From these 3-D images, we measure the volume of
the infants’ ventricles. This system has been validated both
using test phantom ventricles of known volume18 and in vivo
against the volume of CSF withdrawn during a tap as well as
against MRI.19
In this paper, we present for the first time a preliminary study
used to examine whether a 3-D US-based VV and VV change
measurements allow us to prognosticate, which infants with
PHVD will receive a temporary intervention and who will
have a spontaneous resolution of PHVD.
2 Materials and Methods
As part of a larger study, between April 2012 and May 2016,
after an initial diagnosis of IVH1 was made during standard
screening head US exam, preterm neonatal patients were
enrolled with informed parental consent. 3-D US images and
all experimental protocol were acquired in accordance with a
protocol approved by the Research Ethics Board at the
University of Western Ontario. Imaging was performed twice
per week with 3 to 4 days between imaging sessions.
Interventions were performed based on clinical judgement,
with the clinician using the head circumference growth over
time, the increase in ventricular dilatation on the 2-D US, as
well as sometimes, but not necessarily, clinical signs and symp-
toms of increased ICP, such as apnea, bradycardia, and a full,
tense fontanelle. Interventions were not based on 3-D US
images collected during the study, as the clinical team was
blinded to all 3-D US images during the course of the stay
in the neonatal intensive care unit (NICU). The initial interven-
tion at our center is a ventricular tap (VT) since it can be done at
the bedside and does not require an operating room (whereas the
Ommaya catheter insertion does); but if taps are thought to be
needed frequently, then an external ventricle drain is usually
inserted. For the purpose of this study, only patients born
<32-weeks gestational age (GA) were included in the analysis.
2.1 Three-Dimensional US Image Acquisition
Images were acquired using a Philips HDI 5000 US machine
with a C8-5 transducer. 3-D US imaging was performed after
placing the US transducer in a handheld motorized housing
that tilted the transducer about the axis at the probe tip for 8
to 9 s.20 This approach avoids the use of free-hand scanning
using any external tracking such as electromagnetic or optical,
as these methods require additional more expensive technology
and are subject to geometric artifacts due to environmental con-
strains and line of sight. Furthermore, 3-D scanning without
tracking or a motorized fixture is not recommended for accurate
volume measurements from 3-D US images.21
During image acquisition, 2-D US images were collected on
a laptop computer as the motor tilted the transducer over 9.6 s
and in-house software reconstructed the 3-D US image in real-
time as images were received into the computer. Technical
details can be found in Ref. 18. This system has been validated
both for geometric validity and volume measurements.
2.2 Three-Dimensional US Image Segmentation
The lateral ventricles were manually segmented in parallel sag-
ittal slices with 1 mm gaps between adjacent slices. A trained
observer (JK) segmented all the images and a pediatric neuro-
surgeon verified the boundaries (SdR). Each image required
between 20 and 45 min to segment. The 3-D US imaging system
and ventricle segmentation have been previously validated using
phantom and patient images.18 An example of segmented ven-
tricles from a patient with PHVD following IVH is shown
in Fig. 1.
Fig. 1 3-D US images of a preterm neonate with PHVD over the first 3 weeks of life who required multiple
VT to treat the rapid increase in ventricle size. (a) Week 1, (b) week 2, and (c) week 3. Ventricles have
been segmented as indicated by the yellow outline.
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2.3 Determining Which Neonates with PHVD
Received an Initial Ventricle Tap
We performed the analysis of patients who did and did not
receive interventional therapies for PHVD. The VV for each
scan was recorded during the first month of life for each patient
as well as whether or not they eventually received a VT.
2.3.1 Volume measurement as predictive marker
The VV for age ranges <7, 8–11, 12–15, 16–19, 20–22, and 23–
27 days of life was calculated and recorded for each patient.
Volume measurements were not always attainable for every
patient at each time point, as some enrolled late, or were too
unstable to be scanned that day. Given the study population
leaned toward extremely preterm neonates with at minimum
an IVH and often with other morbidities related to prematurity,
instability following minimal handling (such as during a head
US) was more common in this population than it would be
for most NICU patients. For some patients, two measurements
were made within the time periods (i.e., days 8 and 11) and both
were used as independent points.
2.3.2 Maximum rate of change of ventricle volume
We calculated the rate of change of VV between two scans, and
analyzed it for the first week (day <8), second week (days 8 to
14), and third week (days 15 to 21) of life. The neonatal “week
of life” was categorized depending on the week of the second
scan (i.e., if scans were obtained on days 3 and 7 of life, this
would be considered “first week of life” but if scans were
obtained on days 6 and 10 of life, this would be “second
week of life”).
2.4 Determining Which Neonates with PHVD Will
Receive Follow-Up Interventions
Since most patients with PHVD who have an initial VT will go
on to have multiple VTs during the course of the stay in the
NICU, we investigated whether or not image-based measure-
ments could detect whether further treatments would be
received. Thus, we analyzed VV as well as VV change using
the images obtained closest to the initial VT but not on the
day of, and within the week after the VT to see if we could estab-
lish a difference among these patients.
2.5 Comparison to 2-D US-Based Thresholds for
Intervention
Many centers opt to use 2-D US-based measurements as thresh-
olds for intervention. Such measurements have been described
by Brouwer et al.,22and we will be using their cross-sectional
reference curves in this study as they include neonates as
young as 25-weeks GA. The “action” threshold we will report
on is the ventricle index (VI) 97th centile þ4 mm.23 As we did
not use any 2-D US measurements to determine interventions
during the study period, we were perhaps far more conservative
in intervening in these patients than most clinicians would have
been. Thus, we can retrospectively investigate at what point the
neonates in our study would have crossed 2-D US image-based
thresholds in comparison to the 3-D US-based thresholds. Thus,
we report the day of life a patient crossed over an image-based
threshold. As 2-D US VI thresholds were generated using an
independent data set, we directly used our measurements against
the indicated threshold to report the first day of life the patient
had 2-D US-based measurements above the VI 97thþ4 mm if it
occurred, otherwise, the tested date would be reported.
We used leave-one-out cross-validation to investigate 3-D
US-based thresholds. Patient images were binned into time
points previously alluded to (<7, 8 to 11, 12 to 15, 16 to 19,
20 to 22, and 23 to 27 days of life). Some patients had multiple
images within the bin, and if this patient was “left out” all their
images were removed from the test set, and a new threshold was
generated to be tested against and the test patient that was
reported to be above (interventional) or below (noninterven-
tional) the threshold. Test age of life varied based on when
patient was enrolled in the study, with the earliest scan date
used as the test date. This process was repeated separately
for all patients.
2.6 Data Analysis
Receiver operator curves (ROC) were generated among patients
who did and did not receive interventions using 3-D US-based
VVs. In the second study in patients who had previous interven-
tions, ROC analysis was performed using 3-D US-based VVs,
among patients who did not receive further interventions, and
those that received at least one additional intervention. For
each parameter (volume and volume change), optimal threshold
for intervention was estimated using the highest product of sen-
sitivity and specificity. In addition, the area under the ROC
curve (AUC), sensitivity, and specificity were calculated.
Leave-one-out thresholds were generated using the same
method. Assuming a Bonferroni correction, two-sided t-tests
were performed between all previously described compared
groups of patients with an α ¼ 0.05. All analyses were per-
formed using GraphPad Prism 6 (GraphPad Software, San
Diego, California).
3 Results
3.1 Patient Characteristics
Thirty-eight neonates were enrolled prior to the second week of
life (before most patients with PHVD would receive an interven-
tion) and were used to determine thresholds in this study. Of
those, 14 patients received at least one VT. Mean age of enrol-
ment was 9 days of life, and 12 patients were enrolled in the first
week of life (seven did not receive interventions, five had at least
Table 1 Patient characteristics for those who did and did not receive
interventional therapies.
Intervention
(N ¼ 14)
No intervention
(N ¼ 24)
Gestational age
(weeks SD)
27.2 2.3 27.3 2.7
Birth weight (g SD) 1060 300 1040 490
Sex (M/F) 10∕4 16∕8
IVH grade3 (I/II/III/IV) 0∕1∕7∕6 3∕13∕6∕2
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a single VT). Descriptions of the all study patients are shown in
Table 1.
3.2 Determining Which Neonates with PHVD
Receive an Initial Ventricle Tap
3.2.1 Volume measurement as a predictive marker
Table 2 shows the threshold in VV used to determine which
patients did or did not receive a VT intervention for PHVD
for a given patient’s age in days. Sensitivity and specificity
for the threshold used as well as AUC are also given in
Table 2. Figure 2 shows the VV in neonates with PHVD during
the different time periods previously specified as well as the cal-
culated threshold from ROC analysis. In general, using VV, we
found the thresholds that characterized patients who received
interventional therapy with high sensitivity (100% to 91.7%)
and high specificity (100% to 92.9%) during the first three
weeks of life (Table 2). The most ambiguity came during the
second week of life (Table 2, 8 to 11 and 12 to 16 days)
when a portion of the patients who did not receive interventions
had transient increases in ventricle size, reflected in a small
increase in mean volume from 7 to 8 cm3. After this time,
for those patients who did not receive interventions but had tran-
sient, small increases in VV had VVs that eventually decreased
or stabilized to on average be about 7 cm3.
The patients who had interventions saw a continued increase
in VV at every time interval and this can be seen in Fig. 2. The
group differences among patients who did and did not receive
interventions were reflected in the increase in the threshold
between the two groups, as well as the increase in sensitivity
and specificity after day 17 (Table 2).
Table 2 Optimal sensitivity and specificity using the maximum single measurement of 3-D US-based VV, AUC, and volume threshold obtained
from ROC curve specificity/sensitivity maximum. The number of patients for each time interval is indicated as recruitment often happened after the
first week of life, and not all patients were stable enough to image at every time interval.
Age of patient Interventional patients (N) No interventions (N) Sensitivity (%) Specificity (%) AUC Threshold used (cm3)
<7 days 7 8 100 100 1 >9.4
8 to 11 days 14 12 91.7 100 0.98 >10.6
12 to 16 days 14 22 100 92.9 0.99 >20.3
17 to 20 days 8 13 100 100 1 >20.4
21 to 27 days 5 17 100 100 1 >20.9
Fig. 2 Box and whisker plots of the VV of neonatal patients who received an interventional ventricle tap
for clinical reasons (intervention), compared to those who did not receive intervention (no intervention).
Images obtained at (a) 7, (b) 8 to 11, (c) 12 to 16, (d) 17 to 20, and (e) 21 to 27 days of life for patients born
<32-weeks GA. Threshold from ROC analysis is marked as a dotted line. Significant differences from t -
test are indicated as * over the graph.
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3.2.2 Maximum rate of change of ventricle volume
as a predictive marker
Table 3 shows the threshold in the rate of change VV to deter-
mine, which patients did or did not receive a temporary inter-
vention for PHH for different age ranges in days. Sensitivity and
specificity for the threshold used as well as the AUC are also
given in Table 3. Figure 3 shows the rate of change in VV in
neonates with PHVD between those who did and did not receive
interventions during the different age ranges previously speci-
fied. In addition, the threshold calculated in ROC analysis is
shown in Fig. 3 for ease of comparison between time periods.
The rate of change in VV was highly sensitive for detecting
which patients received interventions (100% sensitivity) during
all age intervals monitored (Table 3). The ROC in VVaddition-
ally allowed for more specific thresholds (100% specificity) to
be generated for patients who received interventional therapy in
comparison to a single measurement of VV for all age ranges
except for those of <11 days, which had a sensitivity of 75%
(Table 3). From days 7 to 11, some patients who did not receive
intervention had a transient period of ventricle dilatation that
appeared to resolve by the second week of life when the rate
of change stopped increasing or increased by a small amount
(Fig. 3). The threshold for 7 days of life had a very low N
(five patients total), which should be taken into consideration
as this might not be representative of the total patient group stud-
ied (Table 3).
3.3 Determining Which Neonates with PHVD Will
Receive Follow-Up Interventions
For this study, we examined only the patients who already had
a previous VT. Of the 11 patients with a previous VT, four
resolved clinically without further interventions during their
NICU stay. Table 4 shows 3-D US-based thresholds among
Table 3 Optimal sensitivity and specificity using the maximum rate of change in the first 3 weeks of life in 3-D US VV is reported along with AUC
from ROC curve, and the threshold is reported from ROC curve specificity/sensitivity maximum. The number of patients for each time point is
indicated as recruitment often happened after the first week of life, or patients only had a single VV recorded during their time in the study.
Age of patient Interventional patients (N) No interventions (N) Sensitivity (%) Specificity (%) AUC Threshold used (cm3∕day)
<7 days 2 3 100 100 1 >0.25
<11 days 8 9 100 75 0.82 >1.35
2 weeks 10 18 100 100 1 >2.20
3 weeks 10 19 100 100 1 >2.20
Fig. 3 Box and whisker plot of the rate of change in VV between consecutive imaging sessions for pre-
term neonates born <32-weeks GA who received an interventional ventricle tap for clinical reasons (inter-
vention), compared to those who did not receive intervention (no intervention). Scans taken at (a) 1 week
of life, (b) 11 days of life, (c) second week of life, and (d) third week of life. Threshold from ROC analysis is
marked as a dotted line. Significant differences from t -test are indicated as * over the graph.
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patients who received at least one additional VT, and patients
who had PHVD, which resolved after a single VT. Figure 4(a)
shows the 3-D US-based VV as well as the change in VV
[Fig. 4(b)] among neonates who previously had VT who
received repeated VT and those who had resolving PHVD.
Ventricle volume appeared to remain high in 3-D US images
acquired after a first intervention, and there was no clear thresh-
old among those patients who received further interventional
management [Fig. 4(a)]. Indeed, there was no significant
difference between the average VV for patients who received
additional VT (48.8 12.5 cm3 SD) and patients who
were undergoing resolution of PHVD (45.1 16.1 cm3 SD).
However, when the patient was monitored for an additional im-
aging session and the change of volume could be calculated, it
was clear that patients who did not receive further VT had a
decrease in ventricle size [Fig. 4(b)]. The threshold for change
in VV (< 0.31 cm3∕day) was able to characterize patients who
were resolving versus those receiving further monitoring with a
sensitivity and specificity of 100% (Table 4).
3.4 Comparison to 2-D US-Based Thresholds for
Intervention
For patients who did not require interventions (Table 5), only 1
patient (IVH_P015) out of 20 was categorized incorrectly.
Reported thresholds are based on the “bin” the test date fell
in. In follow-up scans, this patient showed spontaneous resolu-
tion of PHVD. Interventional patients (Table 6) were all appro-
priately categorized using 3-D US VV thresholds. In general,
they were enrolled in the study earlier and had earlier test
dates to reflect that.
Table 7 describes the age in days that each “interventional”
neonate (N ¼ 14) in the study crossed the VI 97th centile
þ4 mm mark as well as when they crossed the 3-D US VV
threshold reported in this study (described in Tables 6). On aver-
age, 3-D US VV could detect that an infant would receive an
intervention 7.1 days before the infant reached the VI 97th cen-
tile þ4 mm mark.
Table 4 Optimal sensitivity and specificity using the maximum VV
and maximum rate of change in VV (ΔVV) in the week following initial
VT from 3-D US is reported along with AUC from ROC curve, and
threshold is reported from ROC curve specificity/sensitivity maximum.
Measurement
Sensitivity
(%)
Specificity
(%) AUC
Threshold
used
VV 75 71.4 0.61 <45.45 cm3
ΔVV 100 100 1 <0.31 cm3∕day
Fig. 4 (a) Box and whisker plot of the VV in the imaging session immediately after VT as well as (b) the
change in VV in consecutive imaging session after VT for patients who received either multiple inter-
ventions, or had resolving ventricle dilatation after a single intervention. Threshold from ROC analysis
is marked as a dotted line. Significant differences from t -test are indicated as * over the graph.
Table 5 Leave-one-out cross-validation for patients who did not have
interventions based on clinical practice at our center. The calculated
thresholds from leave-on-out cross-validation, the test day(s),
whether the patient was above/below the threshold. Bolded values
mean patient were miscatagorized.
Patient Threshold VV (cm3) Test age (days)
IVH_P002 <9.405 2.662 4
IVH_P004 <9.405 5.739 7
IVH_P005 <15.58 3.925 13
IVH_P006 <15.58 4.916 12
IVH_P009 <9.405 3.818 6
IVH_P014 <9.405 3.23 5
IVH_P015 <10.57 15.38 9
IVH_P016 <10.57 9.394 9
IVH_P018 <9.405 7.034 6
IVH_P020 <15.58 5.496 14
IVH_P021 <10.57 4.16 8
IVH_P042 <9.405 6.5 7
IVH_P044 <20.34 12 16
IVH_P046 <13.96 10.18 13
IVH_P047 <9.405 7.23 7
IVH_P049 <20.47 3.36 17
IVH_P050 <20.34 4.05 12
IVH_P054 <8.69 8.66 7
IVH_P058 <20.34 8.45 14
IVH_P059 <20.34 5.75 14
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4 Discussion
In our preliminary study, we presented the potential for 3-D
US-based measurements of VVs from neonatal brain images
to characterize whether or not patients with PHVD will receive
interventions. Specifically, neonates who go on to receive inter-
ventions have larger VVs, {mean 21 14 cm3 for patients who
received interventions versus 5.6 2.1 cm3 for patients who
did not receive interventions during the first week of life
[Fig. 1(a)]}. The patients who received interventions tend to
have larger increases in VV change over time (Fig. 2).
In addition, we were able to show that our reported thresh-
olds were able to predict that a neonate would receive an inter-
vention 7 days before the use of the VI 97th centile þ4 mm
(Table 7). This could help give clinicians more time to inform
parents of upcoming interventions as well as plan the interven-
tions. This is particularly helpful if a neurosurgical consult needs
to be brought into the clinical team to insert ventricular access
devices (reservoirs) and/or ventriculosubgaleal shunts. In addi-
tion, if these results were to hold true in an independent sample
of neonates with PHVD, it would grant an even earlier “early”
time point should a study such as that performed in the ELVIS
(early versus late ventricular interventional study) trial, which
used the VI 97th centile þ4 mm24 be performed using 3-D
US VV.
3-D US-based VV acutely remains very high in the week
following an intervention regardless of whether or not the
patient’s PHVD is resolving (interventional patients had VV
of 48.8 12.5 cm3, whereas patients undergoing resolution
had a VV of 45.1 16.1 cm3). However, neonates who
have PHVD that is resolving do show a change in VV
(−1.9 1.3 cm3∕day) from one 3-D imaging session to the
next. This change is indicative of a reduction in VVor no change
from previous image even in the week immediately after an
intervention and is in comparison to the increase in VV in
patients that receive additional VT (2.4 1.1 cm3∕day).
Though calculating the change in VV requires multiple imaging
sessions, this may prove to be a better indicator than using VV
alone for when to schedule therapies to drain CSF. IVH patients
receiving interventions and certainly those receiving repeated
VTs tend to have serial US images performed as part of clinical
care. Furthermore, given the presented data, there is a high like-
lihood that even immediately after an initial VT even if the ven-
tricles are stable or resolving, VV could very well be above a
threshold VV. This could be due to how much CSF can be
drained at any given VT. Removing larger amounts of CSF
occasionally results in infants transiently appearing ashen,
and in some cases experience a drop in blood pressure, heart
rate, and oxygen saturation that is large enough requiring resus-
citation after the procedure. To mediate adverse effects, knowl-
edge of the VV increase following a tap might help better inform
how much CSF to drain during subsequent interventions.
Currently, it is not known how much CSF is optimal to drain
and practices vary greatly among neurosurgeons; however, it
is known that too little drained (<10 ml∕kg of body weight)
has no effect on ventricle size or ICP.25
Previous mathematical estimates of VV based on 2-D US
images found that there was a significant difference between
patients who received interventions and those who did not.26
This model received 2-D US images spaced at regular angular
intervals and a calculation involving solving an integral using
cylindrical coordinates.27 While fairly simplistic to solve for
those with a background in calculus and geometry, this is a non-
trivial level of knowledge to expect any given physician user to
have. They found very good classification for patients who
received treatment at 21 days of life using 30-mLVVor greater
as a threshold, whereas we found a lower threshold of 20.9 cm3
at 21 to 27 days (Table 2). Brann et al.26 additionally found the
change in VV was more predictive than VV alone with 100%
sensitivity and specificity in both retrospective and prospective
analysis, which concurs with the results of this study.
Admittedly, change in VV is a more challenging metric as it
requires multiple 3-D images. In addition, it should be noted
that although this previous work was performed in the late
1980s, these criteria never made it into clinical practice.
Perhaps the relative difficulty in generating this measurement
was the reasons this method did not translate into general clini-
cal practice. Perhaps there is less user error in the acquisition of
a 3-D US image than attempting to acquire 2-D US images at
equal angular spacing, and therefore, a 3-D US approach is more
realistic to translate into practice.
Neonatal patients in the NICU are also at risk of having pre-
natal ventriculomegaly and this finding could be indicative of
abnormalities such as neural tube defects or trisomy, which
require follow-up after birth. For these neonates with larger
than normal ventricles, the rate of change in VV might be a bet-
ter indicator of which patients have progressive VD and not just
Table 6 Leave-one-out cross-validation for patients who had inter-
ventions based on clinical practice at our center. The calculated
thresholds from leave-on-out cross-validation, the test day(s),
whether the patient was above/below the threshold.
Patient Threshold VV (cm3) Test age (days)
IVH_P007 <10.57 26.14 9
IVH_P012 <9.35 10.15 4
IVH_P013 <9.405 15.15 7
IVH_P019 <10.57 16.66 8
IVH_P041 <9.405 10.21 5
IVH_P043 <10.57 15.907 8
IVH_P045 <9.405 20.4 7
IVH_P052 <10.57 17.41 8
IVH_P055 <9.405 44.75 7
IVH_P057 <10.78 11.43 8
Table 7 The day of life infant crosses the threshold for potential inter-
vention and the day of life the infant received intervention based on
2-D US VI 97th centile þ4 mm+4 mm measurements and 3-D US VV
measurements.
VI 97th þ4 mm 3-D US VV
Median (days) 15 7.1
Range (days) 2 to 29 4 to 9
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large ventricles, which are stable in volume and are likely not to
contribute to signs and symptoms of increases in ICP. Therefore,
while our study did not include patients with prenatal ventricu-
lomegaly, 3-D US VV should be examined in a cohort of
patients with this indication, as it could impact how these
patients’ care is managed.
The relative difficulty of generating VV through manual con-
touring a 3-D US image might prove too difficult for translation
into clinical practice and this is a limitation of the current work.
In light of this and to reduce the burden and length of time of
manual ventricles segmentation from 3-D US images, we have
developed both a semiautomated segmentation algorithm that
can be used online at the bedside and an automated segmenta-
tion algorithm that can be run offline with no user input.28,29
Nevertheless, we used manual segmentation in the work
reported here to minimize any errors due to algorithm segmen-
tation, as change in VV would be very sensitive to these errors.
Further evaluation of the algorithm segmentation methods with
larger number of patients is required to determine best practices
in the implementation of these new methods. The semiauto-
mated segmentation algorithm has been integrated into our
acquisition software and is being used in an ongoing pilot
study to test and improve the method. We also speculate that
a machine-learning approach may be superior to the methods
we have developed and are willing to share our images and
manual segmentations with investigators interested in develop-
ing such methods.
In segmenting the ventricles, the user did not use a purely
boundary-based method as in some regions the boundaries
can be difficult to detect or even not present. Since the user
does not see a boundary all the time, they use prior knowledge
of what shape the ventricle should be. As such, a combined
approach that uses intensity information and searching for boun-
daries while including a shape prior has been our most success-
ful algorithm.
Additional limitations of this work include the use of VT
as the initial intervention and not using quantitative US mea-
surements to determine interventional necessity. There is a
wide variation among centers in whether the intervention is
performed with lumbar puncture, VTs, ventricular reservoirs,
third ventriculostomy, subgaleal shunts, and/or external ven-
tricle drains. Further confounding the use of image-based
metrics, 3-D US might be easier or harder to obtain depending
on the ease of access to the fontanelle after different types of
treatments have been performed. Furthermore, the criteria for
intervention in this study are based on clinical judgment with
multiple clinicians deciding on whether or not to tap, and not
on quantitative measurements, which could hinder the repro-
ducibility depending on the degree of clinical variation in
practice. These limitations and questions of the validity of
3-D US-based VV in this patient population can only be elu-
cidated in a larger study to account for greater variation in
clinical practice.
As such, we have presented a potential clinical use for 3-D
US within the NICU. This type of imaging appears to be prom-
ising to be able to help generate management strategies for neo-
nates at risk of PHVD and the subsequent potential brain
damage from elevated ICP. A larger, multicenter study is
required to generate guidelines as this will increase the patient
pool and better account for differences in clinical practice that
occur in different centers.
Disclosure
No conflicts of interest, financial or otherwise, are declared by
the authors.
Acknowledgments
The authors acknowledge the funding support from Canadian
Institutes of Health Research (CIHR-325624), and Academic
Medical Organization of Southwestern Ontario (AMOSO).
Additional appreciation to Richa Mehta and Alanna Black
for assistance with acquisition of some images used in the
study as well as organizing patient demographic information
presented in this study. This study was facilitated with the sup-
port of the Neonatal-Perinatal Medicine at Victoria Hospital, as
well as all the NICU physicians and nurses. Many thanks to the
ongoing support for the ultrasound technicians involved in the
study as well as the Department of Radiology at Victoria hos-
pital. We would also like to extend special thanks to all of the
families who graciously consented to be included in this
research, for without them, none of this would have been
possible.
References
1. A. R. Synnes et al., “Variations in intraventricular hemorrhage incidence
rates among Canadian neonatal intensive care units,” J. Pediatr. 138,
525–531 (2001).
2. L. A. Papile et al., “Incidence and evolution of subependymal and intra-
ventricular hemorrhage: a study of infants with birth weights less than
1500 gm,” J. Pediatr. 92, 529–534 (1978).
3. E. A. Christian et al., “Trends in hospitalization of preterm infants with
intraventricular hemorrhage and hydrocephalus in the United States,
2000–2010,” J. Neurosurg. Pediatr. 17, 260–269 (2016).
4. M. Zaben et al., “The initial neurosurgical interventions for the treat-
ment of posthaemorrhagic hydrocephalus in preterm infants: a focused
review,” Br. J. Neurosurg. 30, 7–10 (2016).
5. J. H. Badhiwala et al., “Treatment of posthemorrhagic ventricular dila-
tion in preterm infants: a systematic review and meta-analysis of out-
comes and complications,” J. Neurosurg. Pediatr. 1–11 (2015).
6. A. Whitelaw and K. Aquilina, “Management of posthaemorrhagic
ventricular dilatation,” Arch. Dis. Child. Fetal Neonatal Ed. 97,
F229–F223 (2012).
7. M. C. Ingram et al., “Poor correlation between head circumference and
cranial ultrasound findings in premature infants with intraventricular
hemorrhage,” J. Neurosurg. Pediatr. 14, 184–189 (2014).
8. J. Maunu et al., “Brain and ventricles in very low birth weight infants at
term: a comparison among head circumference, ultrasound, and mag-
netic resonance imaging,” Pediatrics 123, 617–626 (2009).
9. N. Haiden et al., “3-D ultrasonographic imaging of the cerebral ven-
tricular system in very low birth weight infants,” Ultrasound Med.
Biol. 31, 7–14 (2005).
10. J. H. Gilmore et al., “Infant cerebral ventricle volume: a comparison of
3-D ultrasound and magnetic resonance imaging,” Ultrasound Med.
Biol. 27, 1143–1146 (2001).
11. M. Riccabona et al., “Potential of three-dimensional ultrasound in neo-
natal and paediatric neurosonography,” Eur. Radiol. 13, 2082–2093
(2003).
12. C. C. Salerno et al., “Three-dimensional ultrasonographic imaging of
the neonatal brain in high-risk neonates: preliminary study,” J.
Ultrasound Med. 19, 549–555 (2000).
13. H. Abdul-Khaliq, P. E. Lange, and M. Vogel, “Feasibility of brain volu-
metric analysis and reconstruction of images by transfontanel three-
dimensional ultrasound,” J. Neuroimaging 10, 147–150 (2000).
14. G. McLean et al., “Measurement of the lateral ventricles in the neonatal
head: comparison of 2-D and 3-D techniques,” Ultrasound Med. Biol.
38, 2051–2057 (2012).
15. J. M. Romero et al., “Time efficiency and diagnostic agreement of 2-D
versus 3-D ultrasound acquisition of the neonatal brain,” Ultrasound
Med. Biol. 40, 1804–1809 (2014).
Journal of Medical Imaging 026001-8 Apr–Jun 2018 • Vol. 5(2)
Kishimoto et al.: Quantitative 3-D head ultrasound measurements of ventricle volume. . .
16. Y. J. Kim et al., “Comparison between 3-dimensional cranial ultra-
sonography and conventional 2-dimensional cranial ultrasonography
in neonates: impact on reinterpretation,” Ultrasonography (Seoul,
Korea) 37 (1), 63–70 (2018).
17. B. C. Warf, “Pediatric hydrocephalus in East Africa: prevalence, causes,
treatments, and strategies for the future,” World Neurosurg. 73, 296–
300 (2010).
18. J. Kishimoto et al., “3D ultrasound system to investigate intraventricular
hemorrhage in preterm neonates,” Phys. Med. Biol. 58, 7513–7526
(2013).
19. J. Kishimoto et al., “In vivo validation of a 3D ultrasound system for
imaging the lateral ventricles of neonates,” Ultrasound Med. Biol. 42,
971–979 (2016).
20. A. Fenster, D. B. Downey, and H. N. Cardinal, “Three-dimensional
ultrasound imaging,” Phys. Med. Biol. 46, R67–R99 (2001).
21. A. Fenster and D. Downey, “3-D Ultrasound Imaging,” Ann. Rev.
Biomed. Eng. 2, 457–475 (2000).
22. M. J. Brouwer et al., “New reference values for the neonatal cerebral
ventricles,” Radiology 262, 224–233 (2012).
23. M. I. Levene, “Measurement of the growth of the lateral ventricles in
preterm infants with real-time ultrasound,” Arch. Dis. Child. 56, 900–
904 (1981).
24. L. S. de Vries, A. J. Brouwer, and F. Groenendaal, “Posthaemorrhagic
ventricular dilatation: when should we intervene?” Arch. Dis. Child.
Fetal Neonatal Ed. 98, F284–F285 (2013).
25. K. L. Kreusser et al., “Serial lumbar punctures for at least temporary
amelioration of neonatal posthemorrhagic hydrocephalus,” Pediatrics
75, 719–724 (1985).
26. B. S. Brann et al., “Measurement of progressive cerebral ventriculome-
galy in infants after grades III and IV intraventricular hemorrhages,”
J. Pediatr. 117, 615–621 (1990).
27. B. S. Brann et al., “Quantification of neonatal cerebral ventricular vol-
ume by real-time ultrasonography. Derivation and in vitro confirmation
of a mathematical model,” J. Ultrasound Med. 9, 1–8 (1990).
28. W. Qiu et al., “User-guided segmentation of preterm neonate ventricular
system from 3-D ultrasound images using convex optimization,”
Ultrasound Med. Biol. 41, 542–556 (2015).
29. W. Qiu et al., “Automatic segmentation approach to extracting neonatal
cerebral ventricles from 3D ultrasound images,” Med. Image Anal. 35,
181–191 (2016).
Biographies for the authors are not available.
Journal of Medical Imaging 026001-9 Apr–Jun 2018 • Vol. 5(2)
Kishimoto et al.: Quantitative 3-D head ultrasound measurements of ventricle volume. . .
